Leucovorin endorsement for autism by FDA falls through. What’s next?

In September, officials touted leucovorin as a potential treatment for thousands of children with autism. Now the FDA is walking back from that claim as the drug is approved for a rare genetic condition, not autism. CNN’s Meg Tirrell reports.